Skip to main content
NCBI home page
Annals of the Rheumatic Diseases logoLink to Annals of the Rheumatic Diseases
. 2003 Feb;62(2):162–167. doi: 10.1136/ard.62.2.162

Diffuse endothelial dysfunction is common to ANCA associated systemic vasculitis and polyarteritis nodosa

A Filer 1, J Gardner-Medwin 1, J Thambyrajah 1, K Raza 1, D Carruthers 1, R Stevens 1, L Liu 1, S Lowe 1, J Townend 1, P Bacon 1
PMCID: PMC1754444  PMID: 12525387

Abstract

Background: Excess cardiovascular mortality complicates systemic rheumatic disease, suggesting an accelerated atheromatous process, which it has been proposed relates to the vascular inflammation common in such diseases. Impaired endothelium dependent vasodilatation is an early marker of atheromatous disease. It has previously been shown that such endothelial cell dysfunction (ECD) occurring in the brachial artery can complicate primary systemic necrotising vasculitis (SNV).

Objective: To determine if ECD occurs in a wider spectrum of primary SNV, if it is restricted to the major arteries, and whether vasculitis subgroup, ANCA status, or renal involvement influenced the endothelial responses.

Methods: Fifty four patients attending the Birmingham vasculitis clinic, including patients with a range of ANCA and non-ANCA associated primary vasculitides, and a group of age matched controls were recruited. The length of patient follow up and disease activity was variable. Disease activity, damage scores, and cardiovascular risk factors were recorded before assessment of flow mediated brachial artery vasodilatation by high resolution ultrasound. Dermal microvascular responses to acetylcholine were also measured in 32 patients and 21 controls by laser Doppler flowmetry.

Results: ECD was demonstrated in all primary SNV subgroups of patients with ANCA associated vasculitis and in polyarteritis nodosa, compared with controls. Significant impairment occurred in both vascular beds, regardless of vessel size targeted in the inflammatory vasculitis, ANCA association and titre, or renal involvement.

Conclusions: Diffuse endothelial dysfunction, a predictor of atherosclerotic disease, is found extensively in primary systemic vasculitis. Involvement of different vascular beds is independent of target vessel size or ANCA association, and is unrelated to local disease expression. It is suggested that this results from a systemic response that may be a consequence of primary vasculitis, but is distinct from the local inflammatory vasculitic process.

Full Text

The Full Text of this article is available as a PDF (141.5 KB).

Figure 1.

Figure 1

Open in a new tab

Brachial artery endothelium dependent vasodilatation split by disease group versus healthy controls. Bars represent median values. *p<0.01 versus controls.

Figure 2.

Figure 2

Open in a new tab

Microvascular endothelium dependent vasodilatation split by disease group versus healthy controls. Bars represent median values. *p<0.01 versus controls.

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Adams M. R., Celermajer D. S. Detection of presymptomatic atherosclerosis: a current perspective. Clin Sci (Lond) 1999 Nov;97(5):615–624. [PubMed] [Google Scholar]
  2. Anderson T. J., Uehata A., Gerhard M. D., Meredith I. T., Knab S., Delagrange D., Lieberman E. H., Ganz P., Creager M. A., Yeung A. C. Close relation of endothelial function in the human coronary and peripheral circulations. J Am Coll Cardiol. 1995 Nov 1;26(5):1235–1241. doi: 10.1016/0735-1097(95)00327-4. [DOI] [PubMed] [Google Scholar]
  3. Bacon P. A., Townend J. N. Nails in the coffin: increasing evidence for the role of rheumatic disease in the cardiovascular mortality of rheumatoid arthritis. Arthritis Rheum. 2001 Dec;44(12):2707–2710. doi: 10.1002/1529-0131(200112)44:12<2707::aid-art456>3.0.co;2-m. [DOI] [PubMed] [Google Scholar]
  4. Bhagat K., Vallance P. Inflammatory cytokines impair endothelium-dependent dilatation in human veins in vivo. Circulation. 1997 Nov 4;96(9):3042–3047. doi: 10.1161/01.cir.96.9.3042. [DOI] [PubMed] [Google Scholar]
  5. Blann A. D. Endothelial cell activation, injury, damage and dysfunction: separate entities or mutual terms? Blood Coagul Fibrinolysis. 2000 Oct;11(7):623–630. doi: 10.1097/00001721-200010000-00006. [DOI] [PubMed] [Google Scholar]
  6. Bruunsgaard H., Skinhøj P., Pedersen A. N., Schroll M., Pedersen B. K. Ageing, tumour necrosis factor-alpha (TNF-alpha) and atherosclerosis. Clin Exp Immunol. 2000 Aug;121(2):255–260. doi: 10.1046/j.1365-2249.2000.01281.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Celermajer D. S., Sorensen K. E., Georgakopoulos D., Bull C., Thomas O., Robinson J., Deanfield J. E. Cigarette smoking is associated with dose-related and potentially reversible impairment of endothelium-dependent dilation in healthy young adults. Circulation. 1993 Nov;88(5 Pt 1):2149–2155. doi: 10.1161/01.cir.88.5.2149. [DOI] [PubMed] [Google Scholar]
  8. Celermajer D. S., Sorensen K. E., Gooch V. M., Spiegelhalter D. J., Miller O. I., Sullivan I. D., Lloyd J. K., Deanfield J. E. Non-invasive detection of endothelial dysfunction in children and adults at risk of atherosclerosis. Lancet. 1992 Nov 7;340(8828):1111–1115. doi: 10.1016/0140-6736(92)93147-f. [DOI] [PubMed] [Google Scholar]
  9. Danesh J., Whincup P., Walker M., Lennon L., Thomson A., Appleby P., Gallimore J. R., Pepys M. B. Low grade inflammation and coronary heart disease: prospective study and updated meta-analyses. BMJ. 2000 Jul 22;321(7255):199–204. doi: 10.1136/bmj.321.7255.199. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Del Papa N., Guidali L., Sironi M., Shoenfeld Y., Mantovani A., Tincani A., Balestrieri G., Radice A., Sinico R. A., Meroni P. L. Anti-endothelial cell IgG antibodies from patients with Wegener's granulomatosis bind to human endothelial cells in vitro and induce adhesion molecule expression and cytokine secretion. Arthritis Rheum. 1996 May;39(5):758–766. doi: 10.1002/art.1780390507. [DOI] [PubMed] [Google Scholar]
  11. Dhillon R., Clarkson P., Donald A. E., Powe A. J., Nash M., Novelli V., Dillon M. J., Deanfield J. E. Endothelial dysfunction late after Kawasaki disease. Circulation. 1996 Nov 1;94(9):2103–2106. doi: 10.1161/01.cir.94.9.2103. [DOI] [PubMed] [Google Scholar]
  12. Dogra G., Rich L., Stanton K., Watts G. F. Endothelium-dependent and independent vasodilation studies at normoglycaemia in type I diabetes mellitus with and without microalbuminuria. Diabetologia. 2001 May;44(5):593–601. doi: 10.1007/s001250051665. [DOI] [PubMed] [Google Scholar]
  13. Exley A. R., Bacon P. A., Luqmani R. A., Kitas G. D., Gordon C., Savage C. O., Adu D. Development and initial validation of the Vasculitis Damage Index for the standardized clinical assessment of damage in the systemic vasculitides. Arthritis Rheum. 1997 Feb;40(2):371–380. doi: 10.1002/art.1780400222. [DOI] [PubMed] [Google Scholar]
  14. Haak E., Abletshauser C., Weber S., Goedicke C., Martin N., Hermanns N., Lackner K., Kusterer K., Usadel K. H., Haak T. Fluvastatin therapy improves microcirculation in patients with hyperlipidaemia. Atherosclerosis. 2001 Apr;155(2):395–401. doi: 10.1016/s0021-9150(00)00567-0. [DOI] [PubMed] [Google Scholar]
  15. Harper L., Savage C. O. Pathogenesis of ANCA-associated systemic vasculitis. J Pathol. 2000 Feb;190(3):349–359. doi: 10.1002/(SICI)1096-9896(200002)190:3<349::AID-PATH524>3.0.CO;2-A. [DOI] [PubMed] [Google Scholar]
  16. Haverkate F., Thompson S. G., Pyke S. D., Gallimore J. R., Pepys M. B. Production of C-reactive protein and risk of coronary events in stable and unstable angina. European Concerted Action on Thrombosis and Disabilities Angina Pectoris Study Group. Lancet. 1997 Feb 15;349(9050):462–466. doi: 10.1016/s0140-6736(96)07591-5. [DOI] [PubMed] [Google Scholar]
  17. Jennette J. C., Falk R. J., Andrassy K., Bacon P. A., Churg J., Gross W. L., Hagen E. C., Hoffman G. S., Hunder G. G., Kallenberg C. G. Nomenclature of systemic vasculitides. Proposal of an international consensus conference. Arthritis Rheum. 1994 Feb;37(2):187–192. doi: 10.1002/art.1780370206. [DOI] [PubMed] [Google Scholar]
  18. Joannides R., Haefeli W. E., Linder L., Richard V., Bakkali E. H., Thuillez C., Lüscher T. F. Nitric oxide is responsible for flow-dependent dilatation of human peripheral conduit arteries in vivo. Circulation. 1995 Mar 1;91(5):1314–1319. doi: 10.1161/01.cir.91.5.1314. [DOI] [PubMed] [Google Scholar]
  19. Khan F., Elhadd T. A., Greene S. A., Belch J. J. Impaired skin microvascular function in children, adolescents, and young adults with type 1 diabetes. Diabetes Care. 2000 Feb;23(2):215–220. doi: 10.2337/diacare.23.2.215. [DOI] [PubMed] [Google Scholar]
  20. Liuzzo G., Goronzy J. J., Yang H., Kopecky S. L., Holmes D. R., Frye R. L., Weyand C. M. Monoclonal T-cell proliferation and plaque instability in acute coronary syndromes. Circulation. 2000 Jun 27;101(25):2883–2888. doi: 10.1161/01.cir.101.25.2883. [DOI] [PubMed] [Google Scholar]
  21. Luqmani R. A., Bacon P. A., Moots R. J., Janssen B. A., Pall A., Emery P., Savage C., Adu D. Birmingham Vasculitis Activity Score (BVAS) in systemic necrotizing vasculitis. QJM. 1994 Nov;87(11):671–678. [PubMed] [Google Scholar]
  22. Manzi S., Meilahn E. N., Rairie J. E., Conte C. G., Medsger T. A., Jr, Jansen-McWilliams L., D'Agostino R. B., Kuller L. H. Age-specific incidence rates of myocardial infarction and angina in women with systemic lupus erythematosus: comparison with the Framingham Study. Am J Epidemiol. 1997 Mar 1;145(5):408–415. doi: 10.1093/oxfordjournals.aje.a009122. [DOI] [PubMed] [Google Scholar]
  23. Martens P. B., Goronzy J. J., Schaid D., Weyand C. M. Expansion of unusual CD4+ T cells in severe rheumatoid arthritis. Arthritis Rheum. 1997 Jun;40(6):1106–1114. doi: 10.1002/art.1780400615. [DOI] [PubMed] [Google Scholar]
  24. Moosig F., Csernok E., Wang G., Gross W. L. Costimulatory molecules in Wegener's granulomatosis (WG): lack of expression of CD28 and preferential up-regulation of its ligands B7-1 (CD80) and B7-2 (CD86) on T cells. Clin Exp Immunol. 1998 Oct;114(1):113–118. doi: 10.1046/j.1365-2249.1998.00695.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  25. Noon J. P., Walker B. R., Hand M. F., Webb D. J. Studies with iontophoretic administration of drugs to human dermal vessels in vivo: cholinergic vasodilatation is mediated by dilator prostanoids rather than nitric oxide. Br J Clin Pharmacol. 1998 Jun;45(6):545–550. doi: 10.1046/j.1365-2125.1998.00718.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  26. Ouviña S. M., La Greca R. D., Zanaro N. L., Palmer L., Sassetti B. Endothelial dysfunction, nitric oxide and platelet activation in hypertensive and diabetic type II patients. Thromb Res. 2001 Apr 15;102(2):107–114. doi: 10.1016/s0049-3848(01)00237-7. [DOI] [PubMed] [Google Scholar]
  27. Perticone F., Ceravolo R., Pujia A., Ventura G., Iacopino S., Scozzafava A., Ferraro A., Chello M., Mastroroberto P., Verdecchia P. Prognostic significance of endothelial dysfunction in hypertensive patients. Circulation. 2001 Jul 10;104(2):191–196. doi: 10.1161/01.cir.104.2.191. [DOI] [PubMed] [Google Scholar]
  28. Prior P., Symmons D. P., Scott D. L., Brown R., Hawkins C. F. Cause of death in rheumatoid arthritis. Br J Rheumatol. 1984 May;23(2):92–99. doi: 10.1093/rheumatology/23.2.92. [DOI] [PubMed] [Google Scholar]
  29. Raza K., Thambyrajah J., Townend J. N., Exley A. R., Hortas C., Filer A., Carruthers D. M., Bacon P. A. Suppression of inflammation in primary systemic vasculitis restores vascular endothelial function: lessons for atherosclerotic disease? Circulation. 2000 Sep 26;102(13):1470–1472. doi: 10.1161/01.cir.102.13.1470. [DOI] [PubMed] [Google Scholar]
  30. Ross R. Atherosclerosis--an inflammatory disease. N Engl J Med. 1999 Jan 14;340(2):115–126. doi: 10.1056/NEJM199901143400207. [DOI] [PubMed] [Google Scholar]
  31. Savage C. O., Pottinger B. E., Gaskin G., Lockwood C. M., Pusey C. D., Pearson J. D. Vascular damage in Wegener's granulomatosis and microscopic polyarteritis: presence of anti-endothelial cell antibodies and their relation to anti-neutrophil cytoplasm antibodies. Clin Exp Immunol. 1991 Jul;85(1):14–19. doi: 10.1111/j.1365-2249.1991.tb05675.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  32. Schönermarck U., Csernok E., Trabandt A., Hansen H., Gross W. L. Circulating cytokines and soluble CD23, CD26 and CD30 in ANCA-associated vasculitides. Clin Exp Rheumatol. 2000 Jul-Aug;18(4):457–463. [PubMed] [Google Scholar]
  33. Sorensen K. E., Celermajer D. S., Georgakopoulos D., Hatcher G., Betteridge D. J., Deanfield J. E. Impairment of endothelium-dependent dilation is an early event in children with familial hypercholesterolemia and is related to the lipoprotein(a) level. J Clin Invest. 1994 Jan;93(1):50–55. doi: 10.1172/JCI116983. [DOI] [PMC free article] [PubMed] [Google Scholar]
  34. Tesar V., Masek Z., Rychlík I., Merta M., Bartůnková J., Stejskalová A., Zabka J., Janatková I., Fuciková T., Dostál C. Cytokines and adhesion molecules in renal vasculitis and lupus nephritis. Nephrol Dial Transplant. 1998 Jul;13(7):1662–1667. doi: 10.1093/ndt/13.7.1662. [DOI] [PubMed] [Google Scholar]
  35. Thambyrajah J., Landray M. J., McGlynn F. J., Jones H. J., Wheeler D. C., Townend J. N. Abnormalities of endothelial function in patients with predialysis renal failure. Heart. 2000 Feb;83(2):205–209. doi: 10.1136/heart.83.2.205. [DOI] [PMC free article] [PubMed] [Google Scholar]
  36. Vane J. R., Anggård E. E., Botting R. M. Regulatory functions of the vascular endothelium. N Engl J Med. 1990 Jul 5;323(1):27–36. doi: 10.1056/NEJM199007053230106. [DOI] [PubMed] [Google Scholar]

Associated Data

This section collects any data citations, data availability statements, or supplementary materials included in this article.

Supplementary Materials

[Web-only Table]
annrheumd_62_2_162__index.html (875B, html)
annrheumd_62_2_162__1.pdf (59KB, pdf)

Articles from Annals of the Rheumatic Diseases are provided here courtesy of BMJ Publishing Group

RESOURCES